Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.
about
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemiaSelective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.Histone deacetylase 1 plays a predominant pro-oncogenic role in Eμ-myc driven B cell lymphomaMLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.A chemical probe toolbox for dissecting the cancer epigenome.Low Concentration of Sodium Butyrate from Ultrabraid+NaBu suture, Promotes Angiogenesis and Tissue Remodelling in Tendon-bones Injury.Molecular underpinnings of HDAC inhibition revealed.Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas.Pluripotent Stem Cells in Adult Tissues: Struggling To Be Acknowledged Over Two Decades.Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response.Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing.HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemia.Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.
P2860
Q26767024-AC787A5F-E8F7-4561-BF21-215C8D454954Q36242646-C4C169D0-7E13-44C1-A8A5-4AC8FB576164Q37439209-2C6E34DF-6224-4BA6-9D94-78B0F127E62BQ37633585-8324A01A-25D7-4F75-BF75-E15EA43C0716Q37702571-104BE1D8-B128-42B9-913D-A87BD590D472Q38806404-1A570206-2DD0-4A7D-8412-B0940DA146C7Q39147132-D04580B2-875F-40FC-9A8F-2F64CC447778Q41268048-F1D5B3F9-B314-4B2A-9258-79A02D4365E6Q42389164-BA5BBC4B-DE0E-4CDD-8910-0B7078FB7ADEQ47614980-A37395B9-E022-44FA-AEEF-0E1CA612B408Q50501923-77AE28D2-251A-41D1-B925-7BD44D5C8958Q50649482-11939B38-7532-4C23-BFCC-E3C060030288Q51732387-61A9631B-F645-4238-894B-2A469094A780Q54730115-94499B2C-1898-4DAD-B38B-2D869809709FQ55337031-C35F4DA3-78CC-4F17-B25E-59C00256814C
P2860
Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Functional-genetic dissection ...... hoid and myeloid malignancies.
@ast
Functional-genetic dissection ...... hoid and myeloid malignancies.
@en
type
label
Functional-genetic dissection ...... hoid and myeloid malignancies.
@ast
Functional-genetic dissection ...... hoid and myeloid malignancies.
@en
prefLabel
Functional-genetic dissection ...... hoid and myeloid malignancies.
@ast
Functional-genetic dissection ...... hoid and myeloid malignancies.
@en
P2093
P2860
P1433
P1476
Functional-genetic dissection ...... hoid and myeloid malignancies.
@en
P2093
Christopher R Vakoc
Colin M House
Eva Vidacs
Fabio Santoro
Geoffrey M Matthews
James R Rusche
Katrina J Falkenberg
Kym Stanley
Leonie A Cluse
P2860
P304
P356
10.1182/BLOOD-2015-03-632984
P407
P577
2015-10-07T00:00:00Z